Pharmacist · Epidemiologist · Public Health Researcher

Yusuff Adebayo Adebisi

Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.

View Publications Get in Touch
250+
Publications
4,700+
Citations
38
h-index
90
i10-index

Google Scholar · Feb 2026 View Profile →

About

Advancing health equity through evidence

Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.

His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.

Read full bio →
Yusuff Adebayo Adebisi — Epidemiologist and Public Health Researcher

Research Domains

Antimicrobial Resistance Tobacco Harm Reduction Smoking Cessation Infectious Disease Epidemiology Pandemic Preparedness Disability & Health

Publications

Selected Publications

A short selection from 250+ peer-reviewed works across high-impact journals.

Nature

Vaccinate people in Africa's prisons against COVID-19

Adebisi YA, Okoya F, Lucero-Prisno DE · 2021

Read →

The Lancet

Antimicrobial resistance and people living with disabilities

Adebisi YA · 2024

Read →

The Lancet Psychiatry

The hidden mental health crisis of antimicrobial resistance

Adebisi YA, Olawade DB, Fajembola A · 2023

Read →

Health Science Reports

Prescribed Medication Burden by Tobacco Smoking and E-Cigarette Use Status

Adebisi YA, Uzairue LI, Farayola RO, Iyagbaye E, Ong CJN, Benson AE, Muzondo NV, Temitope AD · 2026

Read →

Current Addiction Reports

Socioeconomic Disparities in E-Cigarette Use: Patterns, Mechanisms, and Equity Implications

Adebisi YA · 2026

Read →

Recognition

Awards & Honours

2025

World's Top 2% Scientists

Stanford/Elsevier List — among the most influential researchers in public health.

2021

The Diana Award

Recognised for inspiring research capacity building across Africa.

2018

WHO Innovate4AMR Global Finalist

Top 11 globally for antimicrobial stewardship innovation.

Blog

Latest from the Blog

Thoughts on public health, equity, global health policy, and more.

Illustration on antimicrobial resistance and disability inclusion showing a wheelchair user, a health worker, a woman with a hearing aid and a man with a white cane beside a shield protecting against bacteria
Featured

19 August 2026

Why Antimicrobial Resistance Response Must Be Disability-Inclusive

Bacterial antimicrobial resistance was directly attributable to 1.27 million deaths in 2019, and around 1.3 billion people — roughly one in six worldwide — experience significant disability. Drawing on a 2024 correspondence in The Lancet, this article argues that disability inclusion belongs in AMR research, national action plans and antimicrobial stewardship from the start.

Read article →

6 August 2026

Does Vaping Increase the Risk of High Blood Pressure? What Our New Study Found

A systematic review and meta-analysis of 10 population-based studies and more than 700,000 participants found no statistically clear link between exclusive e-cigarette use and hypertension, while dual use of e-cigarettes and cigarettes was associated with 41% higher odds of prevalent and 35% higher risk of incident high blood pressure.

Read article →

9 July 2026

Quitting Smoking, Vaping, and Self-Rated Health: What a New Scottish Study Found

A study of 5,064 adults in the Scottish Health Survey found that current e-cigarette users who were former smokers reported better self-rated health than current cigarette smokers, though perceived health did not clearly vary by time since quitting within the vaping group.

Read article →

9 July 2026

Vaping Among Older Adults in Scotland: What a New Study Found

A nationally representative study of 13,297 adults aged 60 and over in the Scottish Health Survey found current e-cigarette use was low at 4.5% but strongly concentrated among current and former smokers, declining with age and higher in more deprived areas.

Read article →

Contact

Let's collaborate

I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.